Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.
You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.
Other companies in Elicio Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX) and FibroGen (NASDAQ:FGEN).
Elicio Therapeutics has a consensus price target of $9.50.
The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $4.8701 last updated December 31, 2024 at 3:40 PM EST.
There are no upcoming dividends for Elicio Therapeutics.
Elicio Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.
There is no upcoming split for Elicio Therapeutics.
Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.